It is well established that focusing on diversity in clinical trials is essential for developing therapies that are safe and effective for different patient populations.
Professor Andrea Manfrin joined the MHRA in June 2023 as Deputy Director of Clinical Investigations and Trials, to spearhead the regulator’s overhaul of the clinical trial regulations.
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resou
Eleven new digital health start-ups have graduated from PharmStars’ twice-yearly education and mentoring programme, with the latest crop focusing on digital innovations in
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio